Loading…
Applied Nutrition reported FY2026 revenue up 50.9% to GBP161.6 million, with adjusted EBITDA up 40.1% to GBP43.3 million. The company also noted a gross margin decline from higher staff costs and expects higher whey protein costs in FY27.
The company is a protein-supplement maker, so its expected higher whey protein costs signal firmer demand for dry whey. The effect on feed markets is limited because the story is company-specific.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.